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Group B streptococcal diseases in 
neonates
 Since the 1970s, leading cause of life-
threatening infections in newborns
 Neonatal illness/death
 Early- & Late Onset Disease
 Long-term disabilities
 Early Onset Disease (EOD) 
 Incidence :
 Before mid-1990s: 3/1000 live births
 Today, prevention era : 0.3 - 1/1000 live births 
 Meningitis :  10 %
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GBS EOD vertical transmission
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GBS EOD vertical transmissionRisk factor for early-onset disease (EOD) : 
vaginal GBS c lonization at delivery
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GUIDELINES FOR PREVENTION 
OF GBS PERINATAL DISEASE
 Intrapartum antibioprophylaxis
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Stages in the pathogenesis of GBS neonatal







> 4 hours before delivery
Highly effective in preventing GBS EOD (1st clinical trials in late 80s)




Impact of prevention practices
Early- and Late-onset GBS Diseases, U.S.
Incidence of early- and late-onset invasive group B streptococcal disease in 

























































































No effect on GBS LOD
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Antenatal GBS culture-based 
screening
Goal of GBS screening
To predict GBS vaginal (rectal) colonization at the 
time of delivery
 Critical factors influencing accuracy
 Swabbed anatomic sites
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Antenatal GBS culture-based 
screening
Goal of GBS screening
To predict GBS vaginal (rectal) colonization at the 
time of delivery
 Critical factors influencing accuracy
 Swabbed anatomic sites
 Timing of sampling (35-37 wks)





Nucleic Acid Amplification Test (NAAT) 
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Theranostic approach
Alternative to GBS prenatal screening: intrapartum
screening
Turnaround time








30-45 minutes, 24 hrs/7 d, robust
Benitz et al. 1999, Pediatrics, Vol 183 (6)
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 Inclusion of women without prenatal screening/care
 Identification of women with change of GBS status after 35-37 
wks gestation
 Increased accuracy of vaginal GBS colonization status at time of 
labor & delivery
 No antimicrobial susceptibility results (in case of penicillin allergy)
Intrapartum screening theranostic approach: 
Expected advantages & drawback
IAP addressed to right target
 Reduction of inappropriate/unnecessary IAP
 Broader coverage of « at GBS risk women » 




A POCT in the delivery room
Xpert® GBS, Cepheid
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Xpert® GBS for intrapartum screening
 Real Time PCR on GeneXpert system
 Amplification of a conserved region adjacent to the cfb gene 
of GBS
 On vaginal or vagino/rectal swab
 Fully automated
 Easy handling (2 min hands on time)
 Result in 35-45 minutes
 a sample-processing control (SPC) 
 to monitor processing conditions
 internal control (IC)
 to monitor PCR conditions and the absence of reaction inhibition
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Xpert® GBS for intrapartum screening
(selected paper amongst many others)
Diagnostic Accuracy of a Rapid Real-Time Polymerase Chain 
Reaction Assay for Universal Intrapartum Group B Streptococcus 
Screening 
Najoua El Helali, Jean-Claude Nguyen, Aïcha Ly, Yves Giovangrandi and 
Ludovic Trinquart  
Clinical Infectious Diseases 2009;49:417–23
 968 Pregnant women
 Intrapartum Xpert GBS, Cepheid (performed in lab)




 PPV 97.8% PPV 58.3%
 NPV 99.7% NPV 92.1%
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Xpert® GBS 
POC test in the delivery room study
Objectives
Study in CHU Liège / UZ Antwerp, Belgium (900 patients)
1. To assess the practical aspects and analytical 
performances
 Tests performed by midwives
 Evolving team of +/- 50 midwives 
 For screening all women at onset of labor
2. To evaluate the cost-effectiveness of the 
intrapartum screening strategy
 To consolidate the proposal of the European 
Expert Group
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Specimen collection & processing
Initial protocol
Antenatal screening Intrapartum screening
 Vagino/rectal specimen
 Collected at 35-37 weeks’ 
gestation
 Vaginal specimen using a 
double swab
 Collected at onset of labor
Culture
(direct & from Lim broth)
Xpert® GBS
a: Granada           b: StrepB Select                 c,d: GS-CNA
In laboratory In labor room
(surveillance
& QC from lab)
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Test Xpert® GBS: Procedure
 Procedure performed by midwives
 GeneXpert system installed at the Obstetrics facility 
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Indeterminate status 










 Criteria for giving intrapartum antibiotic
prophylaxis
 Presence of defined risk factors
 Positive GBS result of the antenatal screening at
35-37 weeks’ gestation
 Positive result of intrapartum screening provided
by Xpert® GBS test
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Study period 8.04.2014 – 3.10.2014 2.7.2014 – 24.9.2014
Number of deliveries 658 ?
GBS antenatal colonization rate 19.4% 14.7%


















*:  lower inclusion rate among antenatally GBS positive screened women
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Culture results (Liege)
 Colonization rate (35-37 wks)
 19.4% GBS positive
 Performances of the 
antenatal culture 
screening
 Intrapartum culture as 
gold standard
Yancey et al. Obstet Gynecol 1996;88:811-5
Melin, ICAAC 2000
Sensitivity Specificity PPV NPV
67.3 % 94.2 % 68.8 % 93.8 %
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Xpert® GBS results (Liege, 2014)
Intrapartum (IP) culture as gold standard
Pre-study
08.04   26.05   
Pre-study
Number tested /










 Bias : low inclusion rate of known 
GBS positive women
 Wrong handling
Reminder of protocol and 
procedure
Objectives:  Sensitivity > 90% & specificity > 95%
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Xpert® GBS results (Liege, 2014)
Intrapartum (IP) culture as gold standard
Pre-study Study
08.04   26.05   11.08    
Pre-study Study
Number tested /
Number GBS Positive IP 
Culture









NPV 96.7% 91.7% Objectives:  
Sensitivity > 90% & specificity > 95%
30QCMD 2015.10.8/GBS/PM
Xpert® GBS results (Liege, 2014)
Intrapartum (IP) culture as gold standard
Pre-study Study
08.04   26.05   11.08    
Study
 In the lab, Liege
 GBS colonies from discrepant results tested POSITIVE
with Xpert® GBS 
Checking if swab dropped 
in the bottom of the 
cartridge
P.Melin CHU of Liege – NRC for group B streptococci
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Xpert® GBS results (Liege, 2014)
Intrapartum (IP) culture as gold standard
Pre-study Study
08.04   26.05   11.08    
Study
 In the lab, Liege
 GBS colonies from discrepant results tested POSITIVE
with Xpert® GBS 
 In Cepheid
 Analysis of raw data from discrepant results
 Mainly no Ct value for GBS
 Discussion
 No control for presence of specimen on board
Checking if swab dropped 
in the bottom of the 
cartridge
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Xpert® GBS results (Liege, 2014)
Intrapartum (IP) culture as gold standard
Pre-study Study
08.04   26.05   11.08    
Study
 In the lab, Liege
 GBS colonies from discrepant results tested POSITIVE
with Xpert® GBS 
 In Cepheid
 Analysis of raw data from discrepant results
 Mainly no Ct value for GBS
 Discussion
 No control for presence of specimen on board
 To the midwives team
 Reminder of critical steps of the procedure
 Intensive individual training of midwives on site
Gentle rolling of the swab 
in order to eliminate 
excess of mucus
Checking if swab dropped 
in the bottom of the 
cartridge
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Xpert® GBS results (Liege, 2014)
Intrapartum (IP) culture as gold standard
Pre-study Study Revision
08.04   26.05   11.08    10.09 
Pre-study Study Revision
Number tested /
Number GBS Positive IP 
Culture





46.7%   !!
50%  !
93.3%   
100%  
Specificity 98.9% 100% 98.5%
PPV 91.7% 100% 93.3%
NPV 96.7% 91.7% 98.5%
Objectives:  
Sensitivity > 90% & 
specificity > 95%
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Xpert® GBS results (Liege, 2014)









Number GBS Positive IP 
Culture





46.7%   !!
50%  !
93.3%   
100%  
53.8%   !!
54.5%  !
Specificity 98.9% 100% 98.5% 97.6%
PPV 91.7% 100% 93.3% 87.5%
NPV 96.7% 91.7% 98.5% 87.2%
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Xpert® GBS results (Antwerp, 2014)
Intrapartum (IP) culture as gold standard
STUDY







Objectives:  Sensitivity > 90% & specificity > 95%
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Xpert® GBS for intrapartum testing
In Obstetric ward or in the lab !! 
(main papers)


























2013 BJOG 225 Lab 66.7 94.9 64.3 95.4
Abdelazim IA 2013 Aust N Z Obstet
Gynaecol
Authors Lab 98.3 99 97.4 99.4
Park JS et al. 2013 Ann Lab Med 175 Lab 86.6 95.6 65 98.7
Church DL et al. 2011 Diag Microbiol Infect 
Dis
231 Lab 100 100 100 100
De Tejada BM et al. 2011 Clin Microbiol Infect 695 Obst. 85 96.6 85.7 96.3
Young BC et al. 2011 Am J Obstet Gynecol 559 Lab 90.8 97.6 92.2 97.1
El Helali N et al. 2009 Clin Infect Dis 968 Lab 98.6 99.6 97.8 99.7
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Antenatal screening Intrapartum screening
 Vagino/rectal specimen
 Collected at 35-37 weeks’ 
gestation
 Vaginal specimen using a 
double swab
 Collected at onset of labor
Culture
(direct & from Lim broth)
Xpert® GBS
In laboratory In labor room
Specimen collection & processing
Modified protocol restricted to Liege site (2015)







Xpert® GBS results (Liege, July-sept.2015)
Intrapartum (IP) culture as gold standard
(61 deliveries ; 11 GBS positive in IP culture, 18%)
 Difference of operator ??
 Difference of mucus behaviour and interference with PCR, from
time of collection to a few hours later ??
PCR in delivery room
PCR in the lab 12-30 
hours later
Number GBS Positive IP Culture 11 (18%) 8 (15%)
Number of tests performed/
number of positive results
61/8+1 53/8+1
Number of error /Invalid 4 errors /3 invalid (11,5%) 3 errors (5.6%)
Sensitivity 72,7% 100%
Specificity 1 Pos with both PCR, not recovered in culture
100%






Xpert® GBS POCT in the delivery room
 Theoretical superior clinical value 
 versus antenatal screening 
 Looks like easy to perform, BUT …
 Careful training of midwives
 High turn-over in midwives team
 Performances to be verified on EACH site !
 To be supervised closely by the lab
 Need for a internal specimen control
 Role of excess of mucus ?
41QCMD 2015.10.8/GBS/PM
Summary
Xpert® GBS POCT in the delivery room
Not ready as a standalone screening
 High specificity but varying sensitivities !
 Could be combined with risk factor strategy ??
 Some expected improvements to secure the 
result  AND the patient management
Commutability from lab to POC
Not always an unconditional success story
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